Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 21, 2015; 21(43): 12370-12380
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12370
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12370
Time point (mean ± SD) | ||||||
Item | Group | 0 h | 6 h | 12 h | 18 h | P value1 |
Control | 165.8 ± 118.0 | 864.0 ± 471.7 | 1927.5 ± 1079.0 | 1969.6 ± 1201.6 | 0.000 | |
ALT (U/L) | Low dose | 86.4 ± 23.4 | 357.2 ± 119.8 | 705.1 ± 341.5 | 1597.7 ± 998.6 | 0.000 |
High dose | 145.6 ± 106.8 | 524.7 ± 182.5 | 1234.8 ± 784.2 | 1321.2 ± 797.4 | 0.000 | |
P value2 | 0.133 | 0.002 | 0.003 | 0.3 | ||
Control | 228.4 ± 110.4 | 929.3 ± 477.7 | 1779.5 ± 495.9 | 1673.2 ± 668.8 | 0.000 | |
AST (U/L) | Low dose | 192.6 ± 37.5 | 664.7 ± 171.5 | 1027.5 ± 396.9 | 1904.3 ± 794.7 | 0.000 |
High dose | 193.1 ± 99.5 | 694.6 ± 278.7 | 1370.6 ± 502.7 | 1355.2 ± 671.5 | 0.000 | |
P value | 0.556 | 0.158 | 0.001 | 0.192 | ||
Control | 1.11 ± 0.93 | 1.50 ± 0.85 | 2.14 ± 1.51 | 1.55 ± 0.93 | 0.197 | |
GGT (U/L) | Low dose | 0.70 ± 0.48 | 0.88 ± 0.35 | 1.27 ± 1.27 | 2.89 ± 2.42 | 0.008 |
High dose | 0.72 ± 0.47 | 1.00 ± 0.71 | 2.36 ± 1.21 | 2.00 ± 1.08 | 0.001 | |
P value | 0.316 | 0.154 | 0.147 | 0.158 | ||
Control | 50.7 ± 4.9 | 47.3 ± 3.6 | 46.3 ± 4.8 | 45.5 ± 3.6 | 0.031 | |
TP (g/L) | Low dose | 48.3 ± 2.9 | 45.0 ± 2.9 | 44.9 ± 3.2 | 44.6 ± 3.8 | 0.039 |
High dose | 51.6 ± 3.3 | 45.5 ± 2.4 | 48.5 ± 3.6 | 45.6 ± 5.8 | 0.001 | |
P value | 0.101 | 0.212 | 0.094 | 0.849 | ||
Control | 1.95 ± 0.62 | 6.68 ± 1.32 | 16.59 ± 2.16 | 20.13 ± 4.19 | 0.000 | |
TBil (U/L) | Low dose | 1.20 ± 0.30 | 4.35 ± 0.77 | 7.45 ± 4.66 | 14.82 ± 2.06 | 0.000 |
High dose | 1.67 ± 0.43 | 6.23 ± 2.22 | 14.31 ± 2.16 | 12.81 ± 2.29 | 0.000 | |
P value | 0.539 | 0.532 | 0.011 | 0.206 | ||
Control | 1.22 ± 0.37 | 4.27 ± 0.64 | 13.56 ± 1.83 | 16.33 ± 3.46 | 0.000 | |
DBil (U/L) | Low dose | 0.65 ± 0.15 | 2.88 ± 0.47 | 5.25 ± 1.01 | 11.15 ± 1.72 | 0.000 |
High dose | 0.99 ± 0.26 | 4.62 ± 1.82 | 10.95 ± 1.59 | 9.72 ± 1.80 | 0.000 | |
P value | 0.353 | 0.527 | 0.004 | 0.14 | ||
Control | 7.41 ± 1.27 | 4.92 ± 2.54 | 6.83 ± 2.33 | 4.21 ± 1.40 | 0.001 | |
Glu (mmol/L) | Low dose | 6.50 ± 1.21 | 6.30 ± 1.62 | 6.09 ± 1.84 | 4.11 ± 2.13 | 0.012 |
High dose | 7.12 ± 2.05 | 8.54 ± 3.69 | 5.25 ± 2.19 | 5.21 ± 1.02 | 0.002 | |
P value | 0.395 | 0.016 | 0.162 | 0.149 | ||
Control | 42.7 ± 6.1 | 42.0 ± 4.6 | 47.8 ± 10.1 | 41.2 ± 10.0 | 0.754 | |
TT (s) | Low dose | 48.9 ± 3.5 | 49.7 ± 6.6 | 49.5 ± 5.3 | 48.4 ± 0.4 | 0.984 |
High dose | 38.2 ± 6.1 | 46.2 ± 2.0 | 11.5 ± 1.1 | 43.2 ± 1.1 | 0.000 | |
P value | 0.127 | 0.226 | 0.001 | 0.36 | ||
Control | 8.9 ± 0.6 | 10.3 ± 0.3 | 11.7 ± 1.1 | 12.4 ± 0.4 | 0.001 | |
PT (s) | Low dose | 9.9 ± 0.6 | 10.9 ± 0.5 | 12.6 ± 1.9 | 14.2 ± 1.6 | 0.016 |
High dose | 9.1 ± 0.1 | 12.6 ± 0.7 | 11.5 ± 1.1 | 14.8 ± 0.8 | 0.000 | |
P value | 0.077 | 0.003 | 0.618 | 0.076 |
- Citation: Tang GH, Yang HY, Zhang JC, Ren JJ, Sang XT, Lu X, Zhong SX, Mao YL. Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function. World J Gastroenterol 2015; 21(43): 12370-12380
- URL: https://www.wjgnet.com/1007-9327/full/v21/i43/12370.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i43.12370